Skip to main content
logo
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
13.15
-0.05 (-0.38%)
Oct 30, 2026, 10:42 AM EDT - Market open

Eloxx Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
53004461
Market Cap Growth
-10900.00%-100.00%-4.33%-93.53%-61.88%
Enterprise Value
3141418526
Last Close Price
13.200.000.0013.2020.02310.73

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.1500-0.17-0.372.72
P/TBV Ratio
1.15----2.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--2.19---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.26-1.08-0.82-0.75-2.430.77
Net Debt / Equity Ratio
-1.08-0.67-0.81-0.70-0.63-1.12
Net Debt / EBITDA Ratio
--1.25-8.12-0.92-0.190.59
Net Debt / FCF Ratio
3.13-1.27-4.19-1.10-0.210.72
Asset Turnover
--2.71---
Quick Ratio
3.650.280.100.050.834.25
Current Ratio
3.740.310.110.070.874.37
Return on Equity (ROE)
-----615.23%-409.19%
Return on Assets (ROA)
--97.59%-65.81%-94.64%-64.93%-73.91%
Return on Capital Employed (ROCE)
-25.60%54.10%10.10%82.40%1748.90%-120.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.62%-1816666.67%-104766666.67%-452.11%-914.70%-109.55%
FCF Yield
-30.07%-1917272.73%-157166666.67%-380.19%-809.34%-57.61%
Buyback Yield / Dilution
-1502.77%-228.50%-46.22%-18.66%-23.86%-74.36%